Vimarsana
Biggest News Aggregation in the World

Epic Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Epic Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Epic Science Today - Breaking & Trending Today

Augmented reality brings science to life for York primary school kids - Vimarsana News

Augmented reality brings science to life for York primary school kids

Augmented reality brings science to life for York primary school kids

Dr. Ruth Etzioni receives $7.4M NCI grant to assess new cancer diagnostics - Vimarsana News

Dr. Ruth Etzioni receives $7.4M NCI grant to assess new cancer diagnostics

Fred Hutch biostatistician Dr. Ruth Etzioni received a seven-year Outstanding Investigator Award (OIA) from the National Cancer Institute to look at multi-cancer early detection tests, commonly referred to as liquid biopsies, and other novel diagnostic technologies..

Epic Sciences Announces Medicare Coverage for Breast-Cancer Focused ctDNA Gene Panel - Vimarsana News

Epic Sciences Announces Medicare Coverage for Breast-Cancer Focused ctDNA Gene Panel

The 56-gene ctDNA panel is a key component of DefineMBC™, the company’s comprehensive blood biopsy for metastatic breast cancerSAN DIEGO--(BUSINESS WIRE)--Epic Sciences, Inc. announced today that the company’s 56-gene ctDNA panel for genomic profiling of metastatic breast cancer is covered by the MolDX program (admi...

EPIC SCIENCES RAISES $43M IN FIRST CLOSE OF SERIES F FINANCING TO ADVANCE COMPREHENSIVE PROFILING FOR METASTATIC CANCER PATIENTS - Vimarsana News

EPIC SCIENCES RAISES $43M IN FIRST CLOSE OF SERIES F FINANCING TO ADVANCE COMPREHENSIVE PROFILING FOR METASTATIC CANCER PATIENTS

/PRNewswire/ -- Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F...

EPIC SCIENCES RAISES $42M IN FIRST CLOSE OF SERIES F FINANCING TO ADVANCE COMPREHENSIVE PROFILING FOR METASTATIC CANCER PATIENTS - Vimarsana News

EPIC SCIENCES RAISES $42M IN FIRST CLOSE OF SERIES F FINANCING TO ADVANCE COMPREHENSIVE PROFILING FOR METASTATIC CANCER PATIENTS

/PRNewswire/ -- Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F...